Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating an underlying platform update rather than changes to the page content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3, indicating a subsequent update to the study record. This update appears to be a metadata/version change rather than a substantive alteration to the study content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now shows Revision: v3.6.2, indicating a newer version of the study details page. This reflects a version-control update rather than a change to the trial information.SummaryDifference0.0%

- Check56 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is no longer enrolling. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Interception/Treatment label formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

- Check63 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new deployment; the change is limited to metadata without visible content alterations.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page revision. This appears to be a metadata update rather than a change to core content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.